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Nutraceuticals are compounds that provide a health benefit above and beyond basic 
nutrition. The integration 01 these products in the lood industry involves the study 01 
extracti,?n, precipitation ar crystallization processes in arder to concentrate, separate 
and purily a specific compound ar lormulation. Therelore, a last and efficient 
selection 01 lood-approved solvents is required lar a growing number 01 bioactive 
substances that are continuously being identified and tested. However, these 
compounds contain in their structure a variety 01 lunctionat groups that makes them 
difficult to represent by usual thermodynamic models and procedures. 
One goal 01 this work is to present new solubility data 01 hesperitin, quercetin and 
rutin in pure solvents like acetone, ethanol, ethyl acetate, n-hexane and water, in the 
temperature range between 25 and 60°C by using the shake-Ilask method lollowed 
by quantitative analysis. 
Additionally, another goal involves the combination 01 the measured data and that 
already compiled lrom the open literature, to develop a methodology to represent the 
solid-liquid equilibrium 01 nutraceuticals compounds using the the NRTL-SAC model, 
which has been successlully applied in the solubility description 01 high complex 
molecules like drugs. 
The shake-flask method proved to be an adequate method to measure the solubility 
01 nutraceuticals in pure and mixed solvents, in the temperature range between 
25 and 60 oe. The NRTL-SAC model showed to be an appropriate toai to represent 
the solubility 01 these molecules, and suggests its ability to predict solubility in 
solvents not considered during the correlation procedure. 
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